microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
about
Cancer microRNAs: from subtype profiling to predictors of response to therapymiR-155 as a Biomarker in B-Cell MalignanciesClinical significance of microRNAs in chronic and acute human leukemiaEpigenomics of leukemia: from mechanisms to therapeutic applicationsMicroRNA-21 and the clinical outcomes of various carcinomas: a systematic review and meta-analysisMicroRNAs and triple negative breast cancerThe biology and clinical significance of acquired genomic copy number aberrations and recurrent gene mutations in chronic lymphocytic leukemiamiR-150 influences B-cell receptor signaling in chronic lymphocytic leukemia by regulating expression of GAB1 and FOXP1MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemiaMicroRNAs in B-cell lymphomas: how a complex biology gets more complexSerum microRNAs in HIV-infected individuals as pre-diagnosis biomarkers for AIDS-NHL.Prognostic value of miR-21 in various cancers: an updating meta-analysis.Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness.microRNA-1/133a and microRNA-206/133b clusters: dysregulation and functional roles in human cancers.MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.Prognostic role of microRNA-181a/b in hematological malignancies: a meta-analysisExpression of regulatory platelet microRNAs in patients with sickle cell diseaseRole of microRNAs on therapy resistance in Non-Hodgkin's lymphoma.Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.miR-181b is a biomarker of disease progression in chronic lymphocytic leukemiaMicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.IL-4 Up-Regulates MiR-21 and the MiRNAs Hosted in the CLCN5 Gene in Chronic Lymphocytic Leukemia.MicroRNAome genome: a treasure for cancer diagnosis and therapy.Circulating MicroRNAs as Minimally Invasive Biomarkers for Cancer Theragnosis and Prognosis.CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.MiR-181b: new perspective to evaluate disease progression in chronic lymphocytic leukemia.Epstein-Barr Virus MicroRNAs are Expressed in Patients with Chronic Lymphocytic Leukemia and Correlate with Overall Survival.MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review.The role of microRNAs in colorectal cancer.The association of microRNA expression with prognosis and progression in early-stage, non-small cell lung adenocarcinoma: a retrospective analysis of three cohorts.MicroRNAs and Glucocorticoid-Induced Apoptosis in Lymphoid MalignanciesComparison of non-coding RNAs in human and canine cancerDifferential microRNA profiles and their functional implications in different immunogenetic subsets of chronic lymphocytic leukemiaSprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.MicroRNAs as biomarkers in leukemia.Prognostic value of miR-155 in individuals with monoclonal B-cell lymphocytosis and patients with B chronic lymphocytic leukemia.The Antitumor Effect of Metformin Is Mediated by miR-26a in Breast Cancer.The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblastsPro-apoptotic TP53 homolog TAp63 is repressed via epigenetic silencing and B-cell receptor signalling in chronic lymphocytic leukaemia.MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma
P2860
Q24594739-491CBE01-9E99-47E5-8ADB-7B4010FE7BE5Q26746573-8B5D7627-A986-4A30-BD01-2AE63F79648BQ26749533-77C7332F-5A5B-4463-89B7-CE2DB9A7ED01Q26823403-0D1D6D64-1B21-41EE-A80A-FA045A3EAB75Q26851333-F61DF514-BD86-40E8-A86B-FFC1E8C80951Q26862716-D57CC714-53EA-4D3B-A140-3075BFD54CC2Q27024411-49EBEEE4-9BF6-4997-87AF-6ED3E04834C3Q28239225-55B4BB66-6809-442B-BBB7-592EDF01DA47Q28241703-4FBEBCE0-034B-4CFE-892C-3267268E6015Q28254647-B86594E7-9305-4D02-86F8-D4FBEA51CA96Q33893875-70579AD1-B6D1-4F28-914E-1D9CA6596650Q33899211-5DEEC929-67C6-4257-B0EB-996B02228267Q33911224-30BA35FD-7A8E-4241-BC00-47312329F558Q34252329-F3171DB2-5F3C-4641-A3F0-D3A86D1CECFCQ34297723-55A33C51-3DC2-4F45-BDF6-51C4C91895E1Q34637868-03FA9B5E-D992-468E-920B-96F8967865B6Q34674369-DB42FDDE-3351-4E07-A43C-587520FC813AQ34769735-575501D0-7F73-4593-A1F2-B2FED3F80E07Q35220403-00216B01-9AF0-4DAC-9FD2-D607AFC26BCCQ35220412-FB0F9663-2782-484D-A76D-B5464288783EQ35496723-F794E5EE-7A17-403E-AF9A-EFFE6AAA0343Q35613623-8EE80FD1-DB35-496C-AA92-6CB956A01918Q35704188-C4CD51B3-4202-4495-A002-1A1D4E3F389AQ35710995-F035FC6F-8B4E-4E19-9F9C-567ACE29A214Q35824101-85165AFB-6A01-47C9-AF57-FD35A08D424CQ35889836-ED72259A-826E-4820-B1C4-47D72DC0A657Q35949262-4B54B1E7-18CF-41D4-A2C5-C3FC08F19AF5Q36037933-46F689FB-5B1F-4A5A-A472-BECA6DFAAD93Q36096641-6FD81523-C965-4176-9BF7-2CCB3C51599CQ36337417-17BA1E52-8E0F-46FD-967C-A2D2855A97EFQ36602853-A4FC7FF2-A1B1-4BEF-A39C-0B35323658F9Q36746944-9D03FE3E-4591-4933-B15F-1F5715060ACDQ36885677-03E3BF63-7C8F-4124-A500-4250AE98B3AAQ36897123-14B6F4EB-8F28-47E3-A34A-039D7F43A60BQ37043773-6910947C-EE6C-4FAB-9D17-129AA6ED9F69Q37188389-49A378AA-09B1-4334-9A00-34FC0B89323AQ37210093-A03766CB-53A2-4C43-817E-7BDA0DDEB957Q37224370-71E1F15C-8D77-4BD6-8246-8C5CDCE19A2AQ37610897-AB0900E9-059F-427C-B9D9-9E324B42DD62Q37623563-266198BB-B506-4DFF-8742-8C4BB2DB8622
P2860
microRNA fingerprinting of CLL patients with chromosome 17p deletion identify a miR-21 score that stratifies early survival
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 14 April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
microRNA fingerprinting of CLL ...... that stratifies early survival
@en
microRNA fingerprinting of CLL ...... hat stratifies early survival.
@nl
type
label
microRNA fingerprinting of CLL ...... that stratifies early survival
@en
microRNA fingerprinting of CLL ...... hat stratifies early survival.
@nl
prefLabel
microRNA fingerprinting of CLL ...... that stratifies early survival
@en
microRNA fingerprinting of CLL ...... hat stratifies early survival.
@nl
P2093
P2860
P50
P1433
P1476
microRNA fingerprinting of CLL ...... that stratifies early survival
@en
P2093
Elisa Barbarotto
Federica Dimitri
Jianhua Hu
Laura Z Rassenti
Lianchun Xiao
Lynn L Barron
Lynne V Abruzzo
Masayoshi Shimizu
Milena S Nicoloso
P2860
P304
P356
10.1182/BLOOD-2010-01-263889
P407
P50
P577
2010-04-14T00:00:00Z